The poor prognosis of lacrimal gland adenocarcinoma: a clinical study and literature review

被引:1
作者
Liu, Rui [1 ]
Ren, Tingting [1 ]
Li, Jing [1 ]
Wang, Nan [1 ]
Xu, Liangyuan [1 ]
Guo, Qihan [1 ]
Zhang, Hong [2 ]
Ma, Jianmin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Pathol, Beijing 100730, Peoples R China
关键词
Adenocarcinoma; Ductal adenocarcinoma; Lacrimal gland; Prognosis; Treatment; PRIMARY DUCTAL ADENOCARCINOMA; ANDROGEN RECEPTOR; CARCINOMA;
D O I
10.1007/s00432-023-05510-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The incidence of lacrimal gland adenocarcinoma is low. This study was designed to analyze the clinical and prognostic characteristics of lacrimal gland adenocarcinoma. Methods This was a clinical study and literature review; 25 patients diagnosed with lacrimal gland adenocarcinoma by histopathology were enrolled and their medical history data were collected. Results The incidence of bone destruction and surrounding tissue invasion was 52% and 44%, respectively. The incidence of distant metastasis of lacrimal gland adenocarcinoma was about 50%. The 5-year overall survival rate of death or metastasis was 33.5%. Age, sex, laterality, tumor size, pathology type, bone destruction, nerve or perineural invasion, invasion of peripheral tissue, T stage, AR, Her-2 and treatment had no significant correlation with lacrimal adenocarcinoma's prognosis (P > 0.05), while the higher expression of Ki-67 may have higher risk of death or metastasis (P = 0.020). Conclusion The incidence of bone destruction and distant metastasis of lacrimal adenocarcinoma is high and the imaging examination is necessary to assess the risk of distant metastasis. The 5-year survival rate of death or metastasis is 33.5% and the high expression of Ki-67 predicts poor prognosis of lacrimal adenocarcinoma.
引用
收藏
页数:9
相关论文
共 30 条
[1]  
Alkatan H, 2018, WHO classification of tumours of the eye
[2]   Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment [J].
Andreasen, Simon ;
Grauslund, Morten ;
Heegaard, Steffen .
ACTA OPHTHALMOLOGICA, 2017, 95 (03) :299-306
[3]   Epidemiological Trends in Malignant Lacrimal Gland Tumors [J].
Andreoli, Michael T. ;
Aakalu, Vinay ;
Setabutr, Pete .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (02) :279-283
[4]   Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights [J].
Anestis, Aristomenis ;
Zoi, Ilianna ;
Papavassiliou, Athanasios G. ;
Karamouzis, Michalis V. .
MOLECULES, 2020, 25 (02)
[5]   Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation [J].
Bulbul, Ajaz .
OXFORD MEDICAL CASE REPORTS, 2018, (09) :290-292
[6]   Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment [J].
Dennie, Trevor .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
[7]   Primary ductal adenocarcinoma of the lacrimal gland: case report [J].
Ferreira Damasceno, Renato Wendell ;
Holbach, Leonard M. .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2012, 75 (01) :64-66
[8]   Intracapsular High-Grade Ductal Carcinoma In-Situ Ex Pleomorphic Adenoma of the Lacrimal Gland [J].
Garakani, Roya ;
Kersten, Robert ;
Pekmezci, Melike .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 36 (01) :E1-E3
[9]   Clinico-epidemiological analysis of 1000 cases of orbital tumors [J].
Goto, Hiroshi ;
Yamakawa, Naoyuki ;
Komatsu, Hiroyuki ;
Asakage, Masaki ;
Tsubota, Kinya ;
Ueda, Shun-ichiro ;
Nemoto, Rei ;
Umazume, Kazuhiko ;
Usui, Yoshihiko ;
Mori, Hideki .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (05) :704-723
[10]   Magnetic resonance imaging of unilateral lacrimal gland lesions [J].
Gündüz, K ;
Shields, CL ;
Günalp, I ;
Shields, JA .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 241 (11) :907-913